Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | April 19, 2023 09:06am

Gainers

  • Virax Biolabs Group (NASDAQ:VRAX) shares rose 34.2% to $0.81 during Wednesday's pre-market session. The market value of their outstanding shares is at $12.5 million.
  • Genprex (NASDAQ:GNPX) stock increased by 15.78% to $1.1. The company's market cap stands at $57.1 million.
  • Matinas BioPharma Hldgs (AMEX:MTNB) shares moved upwards by 14.85% to $0.58. The market value of their outstanding shares is at $126.0 million.
  • VYNE Therapeutics (NASDAQ:VYNE) stock increased by 14.37% to $3.58. The market value of their outstanding shares is at $11.6 million.
  • BiondVax Pharmaceuticals (NASDAQ:BVXV) stock rose 14.35% to $2.23. The market value of their outstanding shares is at $4.2 million. The company's, Q4 earnings came out 2 days ago.
  • Legend Biotech (NASDAQ:LEGN) shares rose 13.89% to $59.5. The market value of their outstanding shares is at $9.8 billion.

Losers

  • Femasys (NASDAQ:FEMY) stock declined by 26.2% to $0.93 during Wednesday's pre-market session. The company's market cap stands at $11.0 million.
  • Allarity Therapeutics (NASDAQ:ALLR) stock decreased by 23.28% to $0.89.
  • SAB Biotherapeutics (NASDAQ:SABS) stock fell 14.66% to $0.93. The company's market cap stands at $46.8 million. As per the news, the Q4 earnings report came out 3 days ago.
  • Indaptus Therapeutics (NASDAQ:INDP) shares decreased by 14.11% to $2.12. The company's market cap stands at $17.8 million.
  • CNS Pharma (NASDAQ:CNSP) shares declined by 12.23% to $1.79. The market value of their outstanding shares is at $3.9 million.
  • Dermata Therapeutics (NASDAQ:DRMA) stock fell 9.89% to $2.28. The company's market cap stands at $1.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALLR BVXV CNSP DRMA FEMY GNPX INDP LEGN MTNB SABS VRAX VYNE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist